United States · FDA National Drug Code directory
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11534-193_60dcfbf6-d07a-4010-ae77-8a9ae4529828
- Product NDC
- 11534-193
- Form
- TABLET
- Composition / generic term
- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
- Labeler
- SUNRISE PHARMACEUTICAL, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180704
- Source listing expiry
- 20271231
Source-listed ingredients
- DEXTROAMPHETAMINE SACCHARATE — 3.125 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE — 3.125 mg/1
- DEXTROAMPHETAMINE SULFATE — 3.125 mg/1
- AMPHETAMINE SULFATE — 3.125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (11534-193-01) · 11534-193-01
- 1000 TABLET in 1 BOTTLE (11534-193-03) · 11534-193-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →